Skip to content

Harrow HROW Total Assets

Total Assets at other companies

AbbVie logo
AbbVieABBV
$136.46B+0.2%
Bausch + Lomb logo
Bausch + LombBLCO
$13.78B+2.6%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$732.53M+80.5%
Viatris logo
ViatrisVTRS
$36.83B-4.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$24.5B-7.3%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$581.14M+16.1%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's total assets?
Harrow (HROW) reported total assets of $419.54M in Q1 2026.
How has Harrow's total assets changed year-over-year?
Harrow's total assets increased by 15.2% year-over-year, from $364.16M to $419.54M.
What is the long-term trend for Harrow's total assets?
Over 5 years (2020 to 2025), Harrow's total assets has grown at a 47.4% compound annual growth rate (CAGR), from $57.47M to $399.48M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.